As an important downstream target of the K-RAS signaling pathway, the role of PI3K-Akt-mTOR axis in tumor occurrence and development has been validated by a variety of researchers (Hillmann and Fabbro, 2019). The gene discussed is MTOR; the disease is neoplasm.